Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease. Med Decis Making 2001;21(1):28-36
Date
02/24/2001Pubmed ID
11206944DOI
10.1177/0272989X0102100104Scopus ID
2-s2.0-0035085440 (requires institutional sign-in at Scopus site) 147 CitationsAbstract
New medications for HIV reduce mortality and morbidity but require strict adherence. Thus, physicians treating HIV-positive patients must weigh both disease severity and likelihood of adherence when deciding whether to start patients on treatment. A national sample of 495 physicians surveyed via mail responded to clinical scenarios depicting HIV-positive patients and indicated whether they would start patients on medication (response rate = 53%). Scenarios varied on the patient characteristics of gender, disease severity, ethnicity, and risk group. Physicians predicted that patients with less severe disease, former injection drug users, and African American men would be less likely to adhere. Perceived adherence and disease severity influenced treatment decisions. Results are discussed in the context of attitudes about minority groups and injection drug users, which may influence adherence judgments in practice settings. Psychological research to identify better methods of predicting medication adherence may serve to inform medical decision making.
Author List
Bogart LM, Catz SL, Kelly JA, Benotsch EGAuthor
Jeffrey A. Kelly PhD Professor in the Psychiatry and Behavioral Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultAged
Anti-HIV Agents
Antiretroviral Therapy, Highly Active
Decision Support Systems, Clinical
Female
HIV Infections
Humans
Male
Middle Aged
Patient Compliance
Physician-Patient Relations
Practice Patterns, Physicians'
Sick Role
